Patrick Flood-Page

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

Patrick Flood-Page, Andrew Menzies‐Gow, Simon Phipps et al. · Journal of Clinical Investigation · 2003 · 842 citations · Full text

Life Sciences, Immunology, Pathology +15

Eosinophil's Role Remains Uncertain as Anti–Interleukin-5 only Partially Depletes Numbers in Asthmatic Airway

Patrick Flood-Page, Andrew Menzies‐Gow, A B Kay et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 809 citations

Medicine, Immunology, Pharmacology +15

A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma

Patrick Flood-Page, Cheri A. Swenson, Isidore Faiferman et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 745 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics

Andrew Menzies‐Gow, Patrick Flood-Page, Roma Sehmi et al. · Journal of Allergy and Clinical Immunology · 2003 · 275 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Intravenous Anti-IL-5 Monoclonal Antibody Reduces Eosinophils and Tenascin Deposition in Allergen-Challenged Human Atopic Skin

Simon Phipps, Patrick Flood-Page, Andrew Menzies‐Gow et al. · Journal of Investigative Dermatology · 2004 · 99 citations · Full text

Life Sciences, Dermatology, Immunology +14